This Viewpoint argues that evidence shows that transient ischemic attacks are neither benign nor transient and should be retired as a neurological diagnostic te
Kano, Nigeria: A new study found that as compared to low-dose hydroxyurea therapy, moderate-dose hydroxyurea therapy showed no change in stroke incidence rate in children with sickle cell anemia..
Interest in stenting for the treatment of symptomatic high-grade intracranial atherosclerosis may be rekindled after the results of a new trial using a drug-eluting stent.
Risk for subsequent stroke does not differ significantly for outpatient care of transient ischemic attack or minor stroke vs inpatient care, a new meta-analysis suggests.